The BRILINTA Patient Support Program

The BRILINTA Patient Support Program provides helpful educational information, tools, and resources. Here’s what you can do to get the support you need while you are taking BRILINTA.

Call 1-888-512-7454* to get help with any questions you may have about BRILINTA, including:

  • Benefit verification—We can help you with what information is needed to process your benefit verification, which types of insurance we can verify for you, the accuracy of your benefit verification, and other questions
  • Prior authorization—We will obtain the prior authorization form from your insurance company and fax or e-mail it to you or your physician, as well as advise you on how to check its status
  • Finding pharmacies likely to stock BRILINTA
  • Determining your copay for BRILINTA—If you prefer, you can figure out your copay using our Patient Copay Calculator

*7 AM to 9 PM ET daily, including holidays.
The copay amount will be accurate at that time, but could vary by the time you fill the prescription at the pharmacy.

Learn how you can save on BRILINTA

  • All eligible patients get One Month Free††
    • This offer is good for eligible patients purchasing up to a 30-day supply (up to 60 tablets)
  • Commercially insured and cash-paying patients may SAVE†† on refills
    • Commercially insured patients: Eligible patients may pay only $18 per 30-day supply.†† Eligible patients can save on out-of-pocket costs that exceed $18 (up to a $75 savings limit) on each 30-day supply, up to a year††
    • Cash-paying patients: Eligible patients can save up to $75 off each 30-day supply, up to a year
  • If you receive your prescriptions for BRILINTA from a mail-order pharmacy, download the mail-order rebate for BRILINTA

Subject to eligibility rules; restrictions apply.

Find out about BRILINTA Free Trial Offer and Savings Card eligibility requirements. View terms

Receive additional services when you take advantage of the BRILINTA Patient Support Program:

  • Ongoing patient support communications
  • Important Safety Information, including side effects
Get a Free Trial Offer for BRILINTA
All eligible patients get ONE MONTH FREE. Plus, eligible commercially insured and cash-paying patients may save on refills.
Already have a Free Trial Offer? Register it now.
Receive your prescriptions by mail? Download our mail-in reimbursement form.
Learn more about saving on BRILINTA. Start here.
Subject to eligibility rules; restrictions apply.

IMPORTANT SAFETY INFORMATION ABOUT BRILINTA

BRILINTA is used to lower your chance of having another heart attack or dying from a heart attack or stroke, but BRILINTA (and similar drugs) can cause bleeding that can be serious and sometimes lead to death. Instances of serious bleeding, such as internal bleeding, may require blood transfusions or surgery. While you take BRILINTA, you may bruise and bleed more easily and be more likely to have nosebleeds. Bleeding will also take longer than usual to stop.

Call your doctor right away if you have any signs or symptoms of bleeding while taking BRILINTA, including: severe, uncontrollable bleeding; pink, red, or brown urine; vomit that is bloody or looks like coffee grounds; red or black stool; or if you cough up blood or blood clots.

Do not stop taking BRILINTA without talking to the doctor who prescribes it for you. People who are treated with a stent, and stop taking BRILINTA too soon, have a higher risk of getting a blood clot in the stent, having a heart attack, or dying. If you stop BRILINTA because of bleeding, or for other reasons, your risk of a heart attack or stroke may increase. Tell all your doctors and dentists that you are taking BRILINTA. To decrease your risk of bleeding, your doctor may instruct you to stop taking BRILINTA 5 days before you have elective surgery. Your doctor should tell you when to start taking BRILINTA again, as soon as possible after surgery.

Take BRILINTA and aspirin exactly as instructed by your doctor. You should not take a dose of aspirin higher than
100 mg daily because it can affect how well BRILINTA works. Tell your doctor if you take other medicines that contain aspirin. Do not take new medicines that contain aspirin.

Do not take BRILINTA if you are bleeding now, especially from your stomach or intestine (ulcer), have a history of bleeding in the brain, have severe liver problems, or are allergic to ticagrelor or any of the ingredients in BRILINTA.

BRILINTA can cause serious side effects, including bleeding and shortness of breath. Call your doctor if you have new or unexpected shortness of breath or any side effect that bothers you or that does not go away. Your doctor can decide what treatment is needed.

Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. BRILINTA may affect the way other medicines work, and other medicines may affect how BRILINTA works.

Approved uses

BRILINTA is a prescription medicine for people who:
  • Have had a recent heart attack or severe chest pain that happened because their heart wasn’t getting enough oxygen
  • Have had a heart attack or chest pain and are being treated with medicines or procedures to open blocked arteries in the heart

BRILINTA is used with aspirin to lower your chance of having another serious problem with your heart or blood vessels such as heart attack, stroke, or blood clots in your stent if you received one. These can be fatal.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are without prescription coverage and cannot afford your medication, AstraZeneca may be able to help. For more information, please visit www.AstraZeneca.com.

The copay amount to be paid will be accurate at that time, but could vary at the time the prescription is filled at the pharmacy.

This product information is intended for US consumers only.

BRILINTA is a registered trademark of the AstraZeneca group of companies.

©2013 AstraZeneca. All rights reserved. 1179506-2880101 Last Updated 9/13